Literature DB >> 26298612

Venous thromboembolism: An overview.

Karen R Bruni-Fitzgerald1.   

Abstract

Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a common, lethal disorder that affects both hospitalized and nonhospitalized patients. PE and DVT are 2 clinical presentations of VTE and share the same predisposing factors. In most cases, PE is a consequence of DVT. This article discusses the predisposing factors, prevalence, and individuals who are at risk of developing this often life-threatening disease.
Copyright © 2015 Society for Vascular Nursing, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26298612     DOI: 10.1016/j.jvn.2015.02.001

Source DB:  PubMed          Journal:  J Vasc Nurs        ISSN: 1062-0303


  7 in total

Review 1.  New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism.

Authors:  Joo Hee Kim; Kyung-Min Lim; Hye Sun Gwak
Journal:  Biomol Ther (Seoul)       Date:  2017-09-01       Impact factor: 4.634

2.  Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.

Authors:  P Demelo-Rodríguez; E Cervilla-Muñoz; L Ordieres-Ortega; A Parra-Virto; M Toledano-Macías; N Toledo-Samaniego; A García-García; I García-Fernández-Bravo; Z Ji; J de-Miguel-Diez; L A Álvarez-Sala-Walther; J Del-Toro-Cervera; F Galeano-Valle
Journal:  Thromb Res       Date:  2020-05-13       Impact factor: 3.944

3.  Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.

Authors:  F Galeano-Valle; C M Oblitas; M M Ferreiro-Mazón; J Alonso-Muñoz; J Del Toro-Cervera; M di Natale; P Demelo-Rodríguez
Journal:  Thromb Res       Date:  2020-05-15       Impact factor: 3.944

4.  Acceptance of clinical decision support system to prevent venous thromboembolism among nurses: an extension of the UTAUT model.

Authors:  Huixian Zha; Kouying Liu; Ting Tang; Yue-Heng Yin; Bei Dou; Ling Jiang; Hongyun Yan; Xingyue Tian; Rong Wang; Weiping Xie
Journal:  BMC Med Inform Decis Mak       Date:  2022-08-19       Impact factor: 3.298

5.  Administration routes affect thrombolytic effect of catheter-directed thrombolysis with pro-urokinase in treating deep vein thrombosis.

Authors:  Meng Liu; Fuxian Zhang
Journal:  Ann Transl Med       Date:  2018-08

Review 6.  Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review.

Authors:  Francisco Galeano-Valle; Lucía Ordieres-Ortega; Crhistian Mario Oblitas; Jorge Del-Toro-Cervera; Luis Alvarez-Sala-Walther; Pablo Demelo-Rodríguez
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

7.  NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands.

Authors:  J M van den Heuvel; A M Hövels; H R Büller; A K Mantel-Teeuwisse; A de Boer; A H Maitland-van der Zee
Journal:  Thromb J       Date:  2018-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.